Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (2677)	3/4/1998 8:36:00 PM
From: Bill Wexler	Respond to of 7041

<<My guess is that Zonagen's best refute is to let their actions speak louder than any words >> Action #1: Zonagen has dropped from its high of 45 to as low as 13 in the face of a spectacular bull market. Action #2: Zonagen still has not produced any evidence that Vasomax works after the FDA threw their results back in their face. Action #3: Zonagen has not filed an NDA. Action #4: After announcing a phony $10,000,000 "stock buyback", Zonagen still hasn't repurchased a single share. Action #5: Zonagen had its second patent application rejected.